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Background. This study evaluates whether non-contrast cardiac computed tomography
(CCT) can detect chronic myocardial infarction (MI) in patients with irreversible perfusion
defects on nuclear myocardial perfusion imaging (MPI).
Methods. One hundred twenty-two symptomatic patients with irreversible perfusion defect
(N 5 62) or normal MPI (N 5 60) underwent coronary artery calcium (CAC) scanning. MI on
these non-contrast CCTs was visually detected based on the hypo-attenuation areas (dark) in
the myocardium and corresponding Hounsﬁeld units (HU) were measured.
Results. Non-contrast CCT accurately detected MI in 57 patients with irreversible per-
fusion defect on MPI, yielding a sensitivity of 92%, speciﬁcity of 72%, negative predictive value
(NPV) of 90%, and a positive predictive value (PPV) of 77%. On a per myocardial region
analysis, non-contrast CT showed a sensitivity of 70%, speciﬁcity of 85%, NPV of 91%, and a
PPV of 57%. The ROC curve showed that the optimal cutoff value of LV myocardium HU to
predict MI on non-contrast CCT was 21.7 with a sensitivity of 97.4% and speciﬁcity of 99.7%.
Conclusion. Non-contrast CCT has an excellent agreement with MPI in detecting chronic
MI. This study highlights a novel clinical utility of non-contrast CCT in addition to assessment
of overall burden of atherosclerosis measured by CAC. (J Nucl Cardiol 2011;18:96–103.)
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See related editorial, pp. 21–23
INTRODUCTION
The principal cause of morbidity and mortality in all
industrialized nations is coronary artery disease (CAD).
In approximately half of these patients, the initial pre-
sentation of CAD is either myocardial infarction (MI) or
death.
1 Unrecognized MI leads to less effective man-
agement and increased major adverse cardiac events
(MACE). Population-based studies have revealed that
one-fourth of MIs demonstrated by Q waves on the ECG
are clinically unrecognized and estimates of the fre-
quency of unrecognized MI detected in the Framingham
study may well underestimate the true prevalence of the
condition.
2 The 10-year mortality from an unrecognized
MI has been estimated to be 45% to 55%
3,4 comparable
to or even higher than in patients with diagnosed MI.
Given the implications of unrecognized MI, studies are
needed to address screening strategies, risk stratiﬁcation,
and the role of post-infarction therapies in these
patients.
5
Nuclear myocardial perfusion imaging (MPI) has
been widely used as a non-invasive method for the
diagnosis of CAD. In comparative studies with autopsy
ﬁndings, thallium (Tl)-201 myocardial single-photon
emission computed tomography (SPECT) has been
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96shown to accurately assess the extent of MI
6 and myo-
cardial viability for the selection of therapy and for
predicting prognosis.
7-9 Although rest Tc-99m-meth-
oxyisobutyl isonitrile (MIBI) underestimates the extent
of viable myocardium compared with Tl-201 imaging,
however several studies show that sublingual adminis-
tration of nitroglycerin before a rest Tc-99m-MIBI study
improves the detection of defect reversibility in exer-
cise-induced perfusion defects and thus improves the
assessment of myocardial viability in comparison with
the standard Tc-99m-MIBI exercise–rest protocol.
10,11
Coronary artery calcium (CAC) score measured
through non-contrast cardiac computed tomography
(CCT)scanninghasbeenshowntopredictfuturecoronary
events in both asymptomatic and symptomatic patients.
12
Non-contrast CCT has also been used for assessing the
pericardial fat,
13 liver fat, and determining the ﬁeld of
view for CCT angiography (CCTA) to reduce radiation
dose.
14 The potential role of non-enhanced CCT to detect
chronic MI, however, has not been well studied. Areas of
chronic left ventricular (LV) infarction are readily
apparent on non-contrast CCT as regions of hypo-atten-
uation either due to deposition of ﬁbrous or adipose
tissue
15,16 or probably reduced capillary density.
17
We conducted this study to evaluate the accuracy
and feasibility of using non-contrast CCT to detect
chronic MI in patients with irreversible perfusion defect
on MPI. We also deﬁne the optimal cutoff value for LV
myocardium Hounsﬁeld unit (HU) to detect chronic MI.
METHODS
Study Population
Our study included 122 consecutive symptomatic patients
(with exertional angina or dyspnea) who were referred for
coronary CAC scanning at our institution after undergoing an
MPI study. Patients with reversible perfusion defects on MPI
were excluded. Subjects with arrhythmia, renal failure, or
hemodynamic instability were excluded. The characteristics of
the study population are summarized in Tables 1 and 2.
Demographic data and clinical history were retrieved
from the clinical records for all patients in the study group.
Information about any evidence of previous clinical MI was
also collected. MI in these patients was diagnosed by elec-
trocardiogram ﬁndings (ST-segment elevation or depression,
pathologic Q waves, new onset of left bundle branch block)
and abnormal levels of cardiac enzymes.
Non-Contrast CCT Acquisition and Analysis
All CCTs were performed using 64-multidetector CT
scanner (GE Healthcare). Following a scout radiograph of the
chest (antero-posterior and lateral), the coronary arteries were
imaged with 30-40 contiguous and 2.5-mm slices during mid-
diastole using ECG-triggering during a 10-s breath hold. CAC
scoring acquisition was reconstructed at 75% of the R–R
interval with the use of axial planes and multiplanar recon-
struction. All the non-enhanced CCT images were assessed by
two experienced readers for presence and location of MI on
Advantage Windows (AW) 4.4 Workstation (General Electric
Medical Systems, Milwaukee, WI, USA).
Longitudinal views of axial images were evaluated from
base to apex to assess the septal, antero-apical, and lateral LV
wall; coronal images were used to assess the inferior wall. MI
on non-enhanced CCT was visually detected based on the areas
of hypo-attenuation (dark) in the myocardium. Hypo-attenua-
tion was assessed by the consensus of two experienced
observers who blinded to the results of the MPI. The mean HU
of normal and hypo-attenuated area were measured in the
septal, antero-apical, lateral, and inferior LV walls. A standard
region of interest (ROI) of 1 cm
2 was used for the normal
myocardium; and for areas with small hypo-attenuation,
smaller ROI was used (Figure 1).
MPI Acquisition and Analysis
All the MPI scans were performed by the referring phy-
sicians at their respective ofﬁces. A standard imaging protocol
as endorsed by ASNC was used for all patients.
18 All patients
underwent rest and stress imaging with technetium-99m-se-
stamibi (MIBI). Patients who could exercise underwent
treadmill stress using the Bruce protocol to reach 85% of
maximum predicted heart rate. Patients who could not exercise
underwent pharmacological stress using dipyridamole at
142 mg/kg/min infused over 4 min. Patients were asked to
terminate beta-blocker 24 h prior to testing when desirable.
For resting studies, patients were injected with 9-10 mCi of
technetium-99m-sestamibi and SPECT images were acquired
30-45 min after resting injection. All SPECT studies were
acquired on a commercially available camera and computer
using a 180-degree arc, high-resolution parallel-hole collima-
tor; and 64 stops with 20 s per stop for a total imaging time of
25 min. All images were acquired using a 64 9 64 matrix.
Table 1. Demographics of the total study pop-
ulation (N = 122)
Age (years) 63.5 ± 11.9
Sex (M/F) 71 (58.2%)/51 (41.8%)
Risk factors
Hypertension 83 (68.0%)
Cholesterol 81 (66.4%)
Diabetes 35 (28.7%)
Smoker 17 (13.9%)
Family history 58 (47.5%)
Race
Caucasian 66 (54.0%)
Hispanic 26 (21.3%)
Asian 24 (19.7%)
African American 6 (4.9%)
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At peak heart rate, 25-30 mCi of technetium-99m-sestamibi
(dose was weight based) was injected. Patient then underwent
post-stress SPECT image acquisition.
The post-stress and rest MIBI scans were interpreted
using visual assessment of perfusion abnormalities by the
referring physicians. All the readers were nuclear board cer-
tiﬁed and blinded to the results of CT. The short axis data were
displayed in polar map format, with the maps divided into 17
segments. The 17 segments were allocated to the territories of
the different coronary arteries as previously described.
19 For
the sake of comparison with CT, the nuclear study results were
then extrapolated into a 4-region model with the LV wall
divided into septal, antero-apical, lateral, and inferior as done
on CCT. Gating was not performed in all the MPI studies and
thus regional wall motion was not assessed.
Statistical Analysis
Categorical variables are presented as frequencies and
percentages, and continuous variables as mean ± standard
deviations (SD). MPI served as the reference standard for the
diagnosis of regional MI. The area under the receiver operator
characteristics (ROC) curve was calculated for MI assessed by
non-contrast CCT to identify irreversible perfusion defect
detected by MPI. Diagnostic performance and predictive value
of non-contrast CCT for the diagnosis of regions showing MI
Table 2. Characteristics of the groups with normal and irreversible perfusion defect on MPI
Variable
Normal myocardial
perfusion (N 5 60)
Irreversible perfusion
defect (N 5 62) P-value
Age (years) 62 ± 11 64 ± 12 .2
Gender (male) 30 42 .046
Hypertension 67% 69% .7
Hypercholesterolemia 65% 68% .7
Diabetes mellitus 27% 31% .6
Family history of CHD 62% 34% .002
Smoking status 8% 19% .08
Known CAD 35% 50% .09
Septal LV wall HU 37 ± 19 14 ± 19 .0001
Antero-apical LV wall HU 42 ± 16 16 ± 26 .0001
Lateral wall HU 38 ± 19 13 ± 28 .0001
Inferior wall HU 36 ± 26 8 ± 27 .0001
HU, Hounsﬁeld unit.
Figure 1. (A) Axial, non-contrast CCT image demonstrating thin curvilinear hypo-attenuation
(arrows) within distal septal, apical, and distal lateral LV myocardium in subendocardial
distribution. (B) Axial, contrast-enhanced CCT image of the same patient shows thinning of
associated portions (arrows) of the LV myocardium. (C) Sample placement of ROI within infarcted
and normal myocardium on non-contrast CCT image to assess mean HU. ROI 1 mean HU =- 71.9
(infarct), ROI 2 mean HU = 33 (normal myocardium).
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patient level and per region level and expressed as sensitivity,
speciﬁcity, positive predictive value (PPV), and negative pre-
dictive value (NPV) and their corresponding 95% conﬁdence
intervals.
The mean HU of normal and hypo-attenuated area in the
septal, antero-apical, lateral, and inferior LV walls were
compared to their corresponding areas in MPI and a second
ROC was used to determine the myocardial HU threshold to
detect MI using non-enhanced CCT. Intra- and inter-observer
variability was calculated using intra-class correlation coefﬁ-
cient (ICC) in a two-way mixed effects model, and Bland &
Altman models. All statistical analyses were performed using
PASW 18.0 (SPSS Institute Inc., Chicago, IL, USA).
RESULTS
A total of 122 patients were studied, including 62
patients (51%) with an irreversible perfusion defect on
MPI and 60 patients with a normal MPI. The mean age
for this patient cohort was 63.5 ± 12 years and 71(58%)
were males.
Out of the 62 patients with irreversible perfusion
defect on MPI, non-contrast CCT accurately detected
infarct in 57 subjects. Thus, on a per patient level and
using MPI as the reference standard, non-contrast CCT
showed a sensitivity of 92% (95% CI, 82.2-97.3),
speciﬁcity of 72% (95% CI, 59.2-82.9), NPV of 90%
(95% CI, 77.8-96.6), and a PPV of 77% (95% CI, 65.4-
85.8), to detect regions of MI. On a per region level,
non-contrast CCT showed a sensitivity of 70% (95% CI,
59.8-78.1), speciﬁcity of 85% (95% CI, 81.4-88.8), NPV
of 91% (95% CI, 87.6-93.8), and a PPV of 57% (95%
CI, 47.6-65.3) to detect regions of MI on MPI (Table 3).
There was good agreement in the identiﬁcation of hypo-
enhanced regions between MPI and non-contrast CCT
(Figures 2 and 3).
The mean HU of the regions correctly identiﬁed as
infarct or normal was calculated to be 5.1 ± 18.3 and
46.2 ± 8.2 (P\.0001), respectively. Based on a ROC
curve, a reference HU of 21.7 can be used to detect
infarcts on non-contrast CCT with a sensitivity of 97.4%
and speciﬁcity of 98.7% (Figure 4).
In a sub-study analysis, intra- and inter-observer
variability of 25 patients with and without irreversible
perfusion defect detected by MPI was assessed using
visual and corresponding HU criteria methods on CCT.
The intra- and inter-observer variability of CCT mea-
sured normal and hypo-attenuation segments were low
(coefﬁcient of variability of 2% for intra-observer and
6% for inter-observer variability). Furthermore, there
was good intra- and inter-observer agreement to assess
normal vs hypo-attenuated segments in CT (ICC: 0.78
and 0.811, respectively, P = .0001) (Table 4).
In a subgroup of 38 patients, with clinical evidence
of prior MI diagnosed on the basis of electrocardiogram
ﬁndings or abnormal levels of cardiac enzymes (as
described in ‘‘Methods’’ section), hypo-attenuation on
CAC scan was present in 30 patients yielding a sensi-
tivity of 79% to detect chronic MI. Out of these 38
patients with clinical MI, irreversible perfusion defects
on MPI were present in 32 patients.
DISCUSSION
Contrast-enhanced CCTA has been shown to be
comparable to MPI and contrast-enhanced cardiac
magnetic resonance (CMR) in detecting ﬁxed perfusion
defect or scar as areas of late contrast enhancement.
20-23
Hypo-enhanced regions on contrast-enhanced CCTA
have been shown to closely relate to delayed enhance-
ment of iodinated contrast.
24,25 The aim of this study
was to evaluate the ability and feasibility of non-contrast
CCT scans to detect chronic MI in patients with irre-
versible perfusion defect on MPI.
Chronic MI is characterized by a process of ven-
tricular remodeling, fatty replacement (rarefaction), and
in rare cases calciﬁcation. Small studies have docu-
mented that the presence of fat and/or calciﬁcation in the
LV-free wall on non-contrast CCT is consistent with
MI.
16,26,27 Subsequently, areas of infarction are readily
apparent on non-contrast CCT as regions of hypo-
attenuation either due to reduced capillary density
17 or
deposition of adipose tissue.
15,28 CT imaging features of
MI include thin linear or curvilinear fat attenuation
within LV myocardium, most commonly sub-endocar-
dial, often associated with LV wall thinning, and/or
calciﬁcation.
16 Furthermore, the presence of LV myo-
cardial fat deposition in sites of myocardial scarring has
Table 3. Accuracy of non-contrast CCT to detect chronic MI as compared to irreversible perfusion
defects on MPI as the reference
Sensitivity
(95% CI)
Speciﬁcity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
Per patient analysis 91.9% (82.2–97.3) 72.1% (59.2–82.9) 76.7% (65.4–85.8) 89.8% (77.8–96.6)
Per region analysis 69.5% (59.8–78.1) 85.4% (81.4–88.8) 56.6% (47.6–65.3) 91.1% (87.6–93.8)
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Volume 18, Number 1;96–103 Non-contrast CCT can accurately detect chronic MIFigure 2. (A) Axial, non-contrast CCT image demonstrating an infero-septal (arrowheads) and
anterior (arrow) wall infarct. (B) Coronal, non-contrast CCT image conﬁrming the infero-septal
(arrowheads) infarct. Lead artifact makes the assessment of infarct difﬁcult in this view.
(C) Nuclear MPI of the same patient demonstrating the ﬁxed perfusion defects.
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failure.
27
The preliminary results of our study demonstrate
that the non-contrast CCT performed for standard CAC
scoring has an excellent agreement with MPI in
detecting irreversible perfusion defects. Despite a
moderate speciﬁcity of 72%, CAC showed an excellent
sensitivity of 92% to detect irreversible perfusion
defects on. The attenuation levels in the infarcted
myocardium were lower than the normal myocardium
(5.1 ± 18.3 and 46.2 ± 8.2, respectively) and the dif-
ference was statistically signiﬁcant (P\.0001). We
also determined the optimal cutoff value for LV myo-
cardium HU to detect chronic MI as 21.7, yielding a
sensitivity of 97.4% and speciﬁcity of 99.7% based on
the ROC curve. This cutoff can be used as an objective
method of diagnosing MI on CCT in daily clinical
practice with high accuracy (AUC—0.98, 95% CI, 0.96-
0.99).
CAC score measured through non-contrast CCT
scanning has been well validated to predict future cor-
onary events in both asymptomatic and symptomatic
patients.
12 This study highlights a novel clinical utility
of non-contrast CCT in addition to assessment of overall
burden of atherosclerosis measured by CAC, and pro-
vides evidence that it can accurately detect chronic MI.
We illustrate the importance of complete review of the
left ventricle apart from calcium scoring as an addition
to the role of non-contrast CT. This application can
further be used to detect occult scars in asymptomatic
population undergoing CAC scan for risk stratiﬁcation.
Silent or unrecognized MI, which was once thought
to be an unusual presentation of CAD, is now widely
recognized as a prominent manifestation of the disease
process. Past cohort studies have demonstrated that
25%-40% of MIs are clinically unrecognized.
29 These
asymptomatic infarctions escape detection until ulti-
mately an ECG is performed for screening or other
clinical purposes. The true prevalence of unrecognized
MI may be even higher, owing to the insensitivity of Q
waves.
5 Despite its benign clinical presentation the
prognosis for unrecognized MI is about as serious as that
for recovered symptomatic infarction for all cause and
cardiovascular mortality.
2 Thus, there is a need for a
cost effective screening mechanism for early diagnosis
of prior MI to promote early management and poten-
tially improved outcomes.
Although other imaging techniques like late gado-
linium enhancement (LGE) on contrast-enhanced CMR
can detect and characterize MI that is missed by clinical
history, ECG, conventional wall motion,
30,31 or nuclear
Figure 3. Area under ROC curve for accuracy of non-contrast
CCT to detect MI diagnosed by MPI.
Figure 4. ROC curve for accuracy of HU criterion to detect
MI on non-contrast CCT.
Table 4. Intra- and inter-observer variability to
detect MI on non-contrast CCT
Variable D 95% CI ICC P-value
Intra-observer 0.02 -0.05 to 0.09 0.78 .0001
Inter-observer 0.06 -0.01 to 0.13 0.81 .0001
D, mean ratio difference; ICC, intra-class correlation
coefﬁcient.
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32 non-contrast CCT is a less
expensive, non-invasive method for detecting unrecog-
nized MI. There is no incremental radiation or scanning
required beyond the CAC scan, so one can simulta-
neously evaluate for both prior MI and CAC with one
scan, potentially adding incremental value to the CAC
scan at no cost.
The presence of LGE on CMR has been shown to
provide incremental prognostic value to MACE and
cardiac mortality beyond common clinical, angio-
graphic, and functional predictors.
33,34 These occult
myocardial scars have been associated with a high risk
of future cardiac events, and therefore identify a sub-
population of patients who may beneﬁt from more
intensive medical or revascularization treatment strate-
gies. Similarly, the presence and extent of MI as
detected by a non-contrast CCT could also be a predictor
of MACE and cardiac death. The presence of hypo-
attenuation may provide incremental prognostic value
beyond traditional risk factors and markers of subclini-
cal atherosclerosis. Non-contrast CCT may also
represent a better standard for unrecognized MI than
ECG for future population-based studies. Whether these
ﬁndings can result in better patient outcomes by guiding
management decisions, such as implantation of ICDs,
coronary revascularization, or intensive medical treat-
ment, requires additional study.
LIMITATION
The primary limitation of this study is that we used
irreversible perfusion defects on standard rest MIBI as
the reference for detecting chronic MI on CAC scan.
However, it should be noted that rest Tc-99m-MIBI
underestimates the extent of viable myocardium com-
pared with Tl-201 imaging, and thus some of the
irreversible perfusion defects might represent hibernat-
ing viable myocardium. Thus, in this study some of the
true positives on CAC scan could actually have been
false positives. Sublingual administration of NTG before
a rest Tc-99m-MIBI study would be a better reference
standard with improved assessment of myocardial
viability.
Although MPI has been validated as an accurate
tool to identify the presence of MI, it is known to give a
large number of false-positive results, primarily because
of attenuation artifacts. Also, smaller infarcts might be
underestimated or missed by MPI due to its limited
resolution. Thus, some non-contrast CCT scans may
have been classiﬁed as false negatives or false positives
due to false nuclear results. CMR imaging has been
proven to be more sensitive than MPI in the detection of
small and occult MIs. Therefore, additional studies using
CMR with delayed enhancement as the reference stan-
dard are warranted.
CONCLUSION
This study demonstrates that the non-contrast CCT
has an excellent agreement with MPI in detecting
chronic MI. Further prospective studies are warranted to
evaluate the role of non-contrast CCT in infarct
assessment for the management of at-risk patients.
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